Clinical Evidence Behind Wegovy vs Mounjaro Side Effects
Wegovy Side Effects vs Mounjaro: Understanding the Key Differences
When comparing Wegovy side effects vs Mounjaro, the fundamental difference lies in their mechanisms of action. Wegovy (semaglutide) targets GLP-1 receptors exclusively, whilst Mounjaro (tirzepatide) acts on both GIP and GLP-1 receptors as a dual agonist. This difference influences their side effect profiles significantly. Wegovy's most commonly reported side effects include nausea (affecting approximately 44% of patients in STEP trials), diarrhoea, vomiting, and constipation, typically occurring during dose escalation phases. These gastrointestinal effects usually diminish as patients adapt to each dose level over the structured 16-week escalation period.
Mounjaro's dual mechanism may result in different gastrointestinal tolerability patterns, though both medications require careful monitoring during initiation. The key advantage when comparing Wegovy side effects vs Mounjaro lies in the established safety database – Wegovy has extensive real-world data from UK prescribing since its NICE approval in 2023. Both medications are prescription-only medicines requiring clinical assessment and ongoing medical supervision. EverydayMeds provides comprehensive side effect monitoring guidance with each prescription, ensuring patients understand what to expect and when to seek medical advice.
UK Weight Loss Results: Clinical Trial Evidence and Real-World Data
Understanding Wegovy side effects vs Mounjaro requires examining the clinical evidence behind their effectiveness. In the landmark STEP 1 trial, patients taking Wegovy alongside diet and exercise achieved an average weight loss of approximately 15% at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 3 trial demonstrated even higher results of around 16% when combined with intensive behavioural therapy, whilst STEP 5 showed sustained weight loss of 15.2% maintained over two years. These results represent some of the most robust weight management data available for any pharmacological intervention.
When evaluating Wegovy side effects vs Mounjaro clinical outcomes, it's important to note that direct head-to-head comparisons aren't available due to different trial designs and patient populations. However, both medications have demonstrated significant efficacy in their respective clinical programmes. The SELECT cardiovascular outcomes trial further validated Wegovy's benefits, showing a 20% reduction in major cardiovascular events. UK real-world data increasingly supports these clinical trial findings, with NHS and private prescribers reporting positive patient outcomes when treatments are properly supervised and combined with lifestyle modifications.
Pricing and Value for UK Patients: Complete Cost Breakdown
At EverydayMeds, our Wegovy pricing reflects the complete treatment journey, starting with the 0.25mg starter dose at £79.99 for new customers using code FIRST40 at checkout. The dose escalation continues through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the maintenance 2.4mg dose (£209.99). Our bundle options provide convenience for longer-term treatment planning, such as the Intro Trio (0.25mg, 0.5mg, and 1mg) for £299.99, covering the first three months of treatment. Returning customers benefit from the DOSE25 discount code, making ongoing treatment more accessible.
When comparing Wegovy side effects vs Mounjaro costs, both represent significant investments in long-term health outcomes. Our bundle pricing eliminates the need for frequent reordering whilst ensuring consistent supply throughout your treatment journey. The Ultimate Stability Trio provides three months of maintenance 2.4mg supply for £649.99, offering peace of mind for established patients. All prices include our comprehensive clinical support, cold-chain delivery, and ongoing monitoring guidance, representing exceptional value compared to traditional clinic-based prescribing models.
How Wegovy Works: The Science Behind GLP-1 Weight Management
Understanding Wegovy side effects vs Mounjaro requires grasping their different mechanisms of action within the body's appetite regulation systems. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone GLP-1, which is normally released after eating to signal satiety to the brain. By activating GLP-1 receptors in the hypothalamus, Wegovy reduces appetite and food cravings whilst slowing gastric emptying, leading to prolonged feelings of fullness after smaller meals. This mechanism explains many of the gastrointestinal side effects, as the medication is working on the digestive system to create these beneficial metabolic changes. The once-weekly injection maintains consistent medication levels, providing steady appetite suppression throughout the treatment period. Clinical studies demonstrate that this mechanism, when combined with dietary changes and increased physical activity, produces the significant weight loss results seen in the STEP trial programme.
EverydayMeds Ordering Process: From Assessment to Delivery
Our streamlined process begins with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, weight management goals, and any concerns about Wegovy side effects vs Mounjaro options. Our qualified prescribers review every application within 3 working days as standard, or within 24 hours with our express service for urgent requirements. Once approved, your prescription-only medicine is prepared in our GPhC-registered pharmacy (#9012878) and dispatched via next-day delivery using specialist cold-chain transportation to maintain the medication's stability. Each delivery includes detailed injection guidance, side effect monitoring information, and direct access to our clinical team for ongoing support. This comprehensive service ensures you're fully prepared for treatment whilst having professional support readily available throughout your weight management journey.
Storage and Practical Considerations: UK Climate Advantages
One practical advantage when comparing Wegovy side effects vs Mounjaro lies in storage requirements and UK usability. Wegovy pens must be stored in the refrigerator at 2-8°C before first use, but once removed, they remain stable at room temperature (below 30°C) for up to 6 weeks – significantly longer than Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy particularly suitable for UK patients who travel frequently or prefer flexible storage options. The FlexTouch pen design is intuitive and requires no mixing or preparation, with clear dose counters showing exactly how much medication remains. The mandatory dose escalation schedule (0.25mg for weeks 1-4, 0.5mg for weeks 5-8, continuing to 2.4mg maintenance) is designed to minimise side effects whilst maximising therapeutic benefits through gradual adaptation.
UK-Specific Prescribing Patterns and Clinical Insights
Recent UK prescribing data reveals interesting patterns when examining Wegovy side effects vs Mounjaro adoption among different patient populations. NHS England's weight management services increasingly recognise both options, though prescribing criteria remain strict, focusing on patients with BMI ≥35 or BMI ≥30 with weight-related comorbidities. Private prescribing has expanded access for patients meeting MHRA criteria (BMI ≥30 or BMI ≥27 with complications), allowing more personalised treatment selection based on individual side effect tolerance and lifestyle factors. UK endocrinologists report that patients with history of gastroparesis or severe digestive disorders may require extra monitoring regardless of which medication is chosen.
The advantage of specialist UK-based prescribing lies in understanding local patient needs and healthcare system integration. EverydayMeds' clinical team includes prescribers experienced with both medications, enabling informed discussions about Wegovy side effects vs Mounjaro based on your specific circumstances. This expertise proves invaluable when navigating insurance considerations, workplace health schemes, or coordination with NHS care, ensuring your private treatment complements rather than conflicts with existing healthcare relationships.
Making Your Decision: Expert Clinical Support Available
Your choice between these prescription-only medicines shouldn't be made in isolation – our qualified prescribers are available to discuss Wegovy side effects vs Mounjaro based on your individual health profile and weight management goals. Both medications are available through EverydayMeds with the same high standard of clinical support, comprehensive monitoring, and convenient delivery service. New customers can start their assessment today using discount code FIRST40, whilst returning customers benefit from DOSE25 savings. Our clinical team provides ongoing support throughout your treatment journey, ensuring you achieve the best possible outcomes whilst managing any side effects effectively. Visit https://everydaymeds.co.uk/collections/wegovy to begin your confidential assessment, or contact our clinical team for personalised guidance about which option may suit your circumstances best.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
